A Phase I/II Clinical Trial of Nivolumab in Progressive/Relapsed Pediatric Solid Tumors

Next Previous
Trial Profile

A Phase I/II Clinical Trial of Nivolumab in Progressive/Relapsed Pediatric Solid Tumors

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 28 Sep 2016

At a glance

  • Drugs Nivolumab (Primary) ; Cyclophosphamide
  • Indications Solid tumours
  • Focus Therapeutic Use

    • Most Recent Events

    • 28 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top